Skip to main content

Table 2 Susceptibility profile of Gram-positive bacilli and Gram-positive cocci isolated from human skin allografts with and without antimicrobial treatment

From: Bacterial contamination of human skin allografts and antimicrobial resistance: a skin bank problem

Gram-Positive Bacilli Gram-Positive Cocci
Antimicrobial resistance profile Number of isolates (n = 195) Isolates Treatment Antimicrobial resistance profile Number of isolates (n = 124) Isolates Treatment
WT 1ST 1ST/2ND WT 1ST 1ST/2ND
PEN
CFO
27
1
B. cereus
B. subtilis
B. licheniformis
Bacillus sp.
B. vallismortis
2
1
9
3
1



12



PEN
CFO
AZM
20
1
13
S. aureus
S. lugdunensis
CNS
S. haemolyticus
CNS
19
1

12


1

1




PEN–CFO
CFO–EST
PEN–AZM
59
4
1
B. cereus
Paenibacillus sp.
B. cereus
28

2
4
—-
29

1
PEN–CIP
PEN–AZM
CIP–AZM
9
1
1
S. aureus
S. epidermidis
S. epidermidis
S. epidermidis
5
4
1
1






PEN–CFO–EST
PEN–CFO–AZM
10
1
B. cereus
Paenibacillus sp.
B. cereus



2
8

1
CFO–CIP–AZM 6 S. epidermidis
S. saprophyticus
5
1


PEN–CFO–CIP–AZM 54 S. epidermidis
S. capitis
S. saprophyticus
S. aureus
35
17
1
1






Susceptible to all ATM 92 Bacillus sp.
B. subtilis
B. vallismortis
B. pumilus
B. licheniformis
B. cereus
49
25
4
2
1
1
2




4
4



Susceptible to all ATM 19 S. haemolyticus
S. lugdunensis
4
15


  1. 1ST, isolates obtained from skin samples previously submitted to the first cycle of treatment with penicillin and streptomycin in the skin bank; 2ND, isolates obtained from skin samples previously submitted to the second cycle of treatment with vancomycin; ATM, antimicrobials; AZM, azithromycin; CFO, cefoxitin; CIP, ciprofloxacin; CNS, coagulase-negative staphylococci; EST, streptomycin; PEN, penicillin; WT, without treatment